Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

Hepatic Drug Excretion: Influencing Factors

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...

Hepatic Drug Clearance: Role of Transporters

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Investigating the Impact of Carboxylated Polystyrene Nanoplastics in the Liver Using Cell Lines and Precision-Cut Liver Slices.

Liver international : official journal of the International Association for the Study of the Liver·2026

Same author

Microplastics, nanoplastics and liver disease: an emerging health concern?

Nature reviews. Gastroenterology & hepatology·2026

Same author

Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury.

EBioMedicine·2026

Same author

Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapy.

Cancer treatment and research communications·2025

Same author

Investigating the potential of oncolytic viruses in the treatment of melanoma: where do we go from here?

Skin health and disease·2025

Same author

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?

Frontiers in immunology·2025

Search research articles

Related Experiment Video

Updated: May 2, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Polymorphic differences in SOD-2 may influence HCV viral clearance.

Annwyne Houldsworth¹, Magdalena Metzner, Steve Shaw

¹Hepatology and Molecular Medicine Research Groups, Plymouth University Peninsula School of Medicine and Dentistry (PU-PSMD), Plymouth, United Kingdom.

Journal of Medical Virology

|March 11, 2014

Summary

Hepatitis C virus (HCV) infection is linked to oxidative stress. A specific genetic variation in the superoxide dismutase 2 (SOD-2) gene, the CT genotype, is more prevalent in individuals with HCV.

Keywords:

SOD-2 antioxidant gene polymorphism hepatitis C virus clearance

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Related Experiment Videos

Last Updated: May 2, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Area of Science:

Genetics
Hepatology
Molecular Biology

Background:

Hepatitis C virus (HCV) infection affects 3% of the global population, often leading to chronic liver disease.
Oxidative stress is implicated in the pathogenesis of HCV infection and its complications like liver cancer.
Antioxidant gene polymorphisms may influence cellular oxidative stress and disease progression in HCV.

Purpose of the Study:

To investigate the association between a specific polymorphism in the superoxide dismutase 2 (SOD-2) gene and Hepatitis C virus (HCV) infection.
To determine if variations in the SOD-2 gene correlate with viral load or disease status in HCV patients.

Main Methods:

Genotyping of the SOD-2 mitochondrial targeting sequence polymorphism (Ala/Val, C-9T substitution) using PCR and polyacrylamide gel electrophoresis.
Analysis of genotype frequencies in patients with HCV (RNA positive), uninfected exposed individuals, and healthy controls.
Statistical comparison of genotype distributions between different study groups.

Main Results:

The 'CT' genotype of the SOD-2 polymorphism was significantly more frequent in the RNA positive HCV group compared to the RNA negative group (89.3% vs. 66.1%, P=0.001).
The 'TT' genotype was less frequent in the RNA positive group than in the RNA negative group (6.80% vs. 27.4%, P=0.01).
An increased frequency of the 'CT' genotype was observed in both the exposed uninfected group and HCV RNA positives compared to controls.

Conclusions:

The 'CT' genotype of the SOD-2 polymorphism is associated with a higher risk or prevalence of Hepatitis C virus infection.
This finding suggests a potential role for oxidative stress, influenced by SOD-2 genetic variations, in the susceptibility or progression of HCV infection.